Clinical and Molecular Hepatology (Clin Mol Hepatol, CMH)

Review

Therapeutic mechanisms and beneficial effects of non-antidiabetic drugs in chronic liver diseases

Han Ah Lee, Young Chang, Pil Soo Sung, Eileen L. Yoon, Hye Won Lee, Jeong-Ju Yoo, Young-Sun Lee, Jihyun An, Do Seon Song, Young Youn Cho, Seung Up Kim, Yoon Jun Kim

Clin Mol Hepatol. 2022;28(3):425-472. Published online July 1, 2022

DOI: https://doi.org/10.3350/cmh.2022.0186

View: 8070 Download: 389 Web of Science: 13 Crossref: 14

Current status and strategies for hepatitis B control in Korea

Eun Ju Cho, Sung Eun Kim, Ki Tae Suk, Jihyun An, Soung Won Jeong, Woo Jin Chung, Yoon Jun Kim

Clin Mol Hepatol. 2017;23(3):205-211. Published online September 19, 2017

DOI: https://doi.org/10.3350/cmh.2017.0104

View: 13185 Download: 311 Web of Science: 85 Crossref: 85

Current status and strategies for viral hepatitis control in Korea

Dong Hyun Sinn, Eun Ju Cho, Ji Hoon Kim, Do Young Kim, Yoon Jun Kim, Moon Seok Choi

Clin Mol Hepatol. 2017;23(3):189-195. Published online September 19, 2017

DOI: https://doi.org/10.3350/cmh.2017.0033

View: 8998 Download: 244 Web of Science: 20 Crossref: 20

Management of viral hepatitis in liver transplant recipients

Soung Won Jeong, YoungRok Choi, Jin-Wook Kim

Clin Mol Hepatol. 2014;20(4):338-344. Published online December 24, 2014

DOI: https://doi.org/10.3350/cmh.2014.20.4.338

View: 8849 Download: 80 Web of Science: 3 Crossref: 3

Original Article

Socioeconomic costs of liver disease in Korea

Sunmi Lee, Woojin Chung, Kyung-Rae Hyun

Clin Mol Hepatol. 2011;17(4):274-291. Published online December 26, 2011

DOI: https://doi.org/10.3350/kjhep.2011.17.4.274

View: 16247 Download: 52 Crossref: 21

3

Factors associated with Liver stiffness in chronic Liver disease

Da Mi Lee, M.D., Eun Joon Moon, M.D., Joo An Hwang, M.D., Min Suk Lee, M.D., Jae Youn Cheong, M.D., Sung Won Cho, M.D., Yeong Bae Kim, M.D. Dong Joon Kim, M.D. Seong Gyu Hwang, M.D. Jin Mo Yang, M.D.

Clin Mol Hepatol. 2009;15(4):464-473. Published online December 31, 2009

DOI: https://doi.org/10.3350/kjhep.2009.15.4.464

View: 4836 Download: 32 Crossref: 4

Clinical Outcomes after Discontinuation of Lamivudine in Chronic Hepatitis B Patients with Lamivudine Resistant HBV Mutant

Jeong Ki Kim, M.D. Seong Gyu Hwang, M.D. Hyeuk Park, M.D. Hong Youp Choi, M.D. Hyo Jin Cho, B.S. Kwang Hyun Ko, M.D. Sung Pyo Hong, M.D. Pil Won Park, M.D. Nam Keun Kim, Ph.D. and Kyu Sung Rim, M.D.

Clin Mol Hepatol. 2005;11(3):227-242. Published online January 1, 1970

View: 3090 Download: 14

Predictive Factors and Clinical Outcome of Viral Breakthrough during Lamivudine Treatment for Chronic Hepatitis B Infection

Park Neunghwa , Sin Jeongu , Park Jongho , Bang Seongjo , Kim Daehyeon , Ju Gwanglo , Kim Doha

Clin Mol Hepatol. 2003;9(4):293-303. Published online January 1, 1970

View: 2402 Download: 12

Efficacy of Lamivudine Re-treatment and Relapse Patterns after Initial Lamivudine Treatment for Chronic Hepatitis B Infection

Jong Ho Park, M.D., Neung Hwa Park, M.D., Jung Woo Shin, M.D., Sung-Jo Bang, M.D., Dae-Hyun Kim, M.D., Kwang Ro Joo, M.D. and Do Ha Kim, M.D.

Clin Mol Hepatol. 2003;9(3):188-197. Published online January 1, 1970

View: 2547 Download: 13

2

Special Oromucosal Cytokine Therapy : Mechanism(s) of Action

Michael G. Tovey

Clin Mol Hepatol. 2002;8(2):125-131. Published online January 1, 1970

View: 4138 Download: 27

3

The Effect of Lamivudine Therapy for Chronic Liver Disease due to Hepatitis B Virus Infection

Neung Hwa Park,Kwang Ro Joo,Do Ha Kim

Clin Mol Hepatol. 2001;7(1):77-89. Published online January 1, 2000

View: 2532 Download: 20

The Role of Dendritic Cell , HLA-DR and CD8+ Presenting Lymphocytes in Chronic Viral Hepatitis : An Immunohistochemical Study

Sang Wook Choi,Don Hyun Jo,Sung Soo Kim,Jin Mo Yang,Byung Min An,Nam Ik Han,Chang Don Lee,Gyu Won Jung,Hee Sik Sun

Clin Mol Hepatol. 2000;6(4):448-455. Published online January 1, 2000

View: 1993 Download: 13

Clinical Study of the Acute Hepatitis due to Salmonella typhi

Sang Woo Lee,Seung Won Seo,Heyng Woong Yang,Jae Kyu Seong,Seung Min Lee,Byung Seok Lee,Nam Jae Kim,Heon Young Lee

Clin Mol Hepatol. 2000;6(3):350-359. Published online January 1, 2000

View: 2499 Download: 36

Novel Maintenance Therapy with Lamivudine in Patients with Chronic Active Viral Hepatitis B

Sung Pyo Hong, M.D., Chang Il Kwon, M.D., June Sung Lee, M.D., Kyung Chul Kim, M.D., Sung Kyu Hwang, M.D., Pil Won Park, M.D., Gyu Sung Rim, M.D. and Sehyun Kim, Ph.D.

Clin Mol Hepatol. 2000;6(3):301-310. Published online January 1, 2000

View: 2287 Download: 12

Evaluation of Oral Thymomodulin Effect on the Patients with Chronic Viral Hepatitis B

Chul Hun Chung , Soong Hwan Lee , Yong Hyeon Jo , Yeon Soo kim , Seung Woo Nam , Oh Young Lee , Dong Soo Ha , Joo Hyun Sohn , Dong Hoo Lee

Clin Mol Hepatol. 1996;2(1):47-53.

View: 3318 Download: 40

1 |

Viewed By 6029	Evaluating the therapeutic efficacy of NAD supplementation in management of metabolic dysfunction-associated steatotic liver disease: Key considerations
Viewed By 5560	2022 KLCA-NCC Korea practice guidelines for the management of hepatocellular carcinoma
Viewed By 5357	MAFLD: How is it different from NAFLD?
Viewed By 5326	Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma
Viewed By 4904	Global incidence and prevalence of nonalcoholic fatty liver disease

Cited By 208	Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma
Cited By 146	Global incidence and prevalence of nonalcoholic fatty liver disease
Cited By 119	2022 KLCA-NCC Korea practice guidelines for the management of hepatocellular carcinoma
Cited By 109	MAFLD: How is it different from NAFLD?
Cited By 94	Forecasted 2040 global prevalence of nonalcoholic fatty liver disease using hierarchical bayesian approach

Search